186 related articles for article (PubMed ID: 10466818)
1. Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization.
Speckner A; Glykofrydes D; Ohlin M; Mach M
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2183-2191. PubMed ID: 10466818
[TBL] [Abstract][Full Text] [Related]
2. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
[TBL] [Abstract][Full Text] [Related]
3. Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus.
Wiegers AK; Sticht H; Winkler TH; Britt WJ; Mach M
J Virol; 2015 Jan; 89(1):361-72. PubMed ID: 25320309
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a discontinuous neutralizing epitope on glycoprotein B of human cytomegalovirus.
Spindler N; Rücker P; Pötzsch S; Diestel U; Sticht H; Martin-Parras L; Winkler TH; Mach M
J Virol; 2013 Aug; 87(16):8927-39. PubMed ID: 23740990
[TBL] [Abstract][Full Text] [Related]
5. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
Navarro D; Lennette E; Tugizov S; Pereira L
J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
[TBL] [Abstract][Full Text] [Related]
6. The antigenic domain 1 of human cytomegalovirus glycoprotein B contains an intramolecular disulphide bond.
Speckner A; Kropff B; Knör S; Mach M
J Gen Virol; 2000 Nov; 81(Pt 11):2659-2663. PubMed ID: 11038377
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response.
Urban M; Klein M; Britt WJ; Hassfurther E; Mach M
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1537-47. PubMed ID: 8757997
[TBL] [Abstract][Full Text] [Related]
9. A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B.
Lantto J; Fletcher JM; Ohlin M
J Gen Virol; 2002 Aug; 83(Pt 8):2001-2005. PubMed ID: 12124464
[TBL] [Abstract][Full Text] [Related]
10. Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus.
Lantto J; Fletcher JM; Ohlin M
Virology; 2003 Jan; 305(1):201-9. PubMed ID: 12504553
[TBL] [Abstract][Full Text] [Related]
11. The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope.
Meyer H; Masuho Y; Mach M
J Gen Virol; 1990 Oct; 71 ( Pt 10)():2443-50. PubMed ID: 1700066
[TBL] [Abstract][Full Text] [Related]
12. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
Cole KS; Alvarez M; Elliott DH; Lam H; Martin E; Chau T; Micken K; Rowles JL; Clements JE; Murphey-Corb M; Montelaro RC; Robinson JE
Virology; 2001 Nov; 290(1):59-73. PubMed ID: 11883006
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies.
Kropff B; Burkhardt C; Schott J; Nentwich J; Fisch T; Britt W; Mach M
PLoS Pathog; 2012; 8(10):e1002999. PubMed ID: 23133379
[TBL] [Abstract][Full Text] [Related]
14. Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.
Reuter N; Kropff B; Schneiderbanger JK; Alt M; Krawczyk A; Sinzger C; Winkler TH; Britt WJ; Mach M; Thomas M
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641474
[TBL] [Abstract][Full Text] [Related]
15. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.
Ohlin M; Sundqvist VA; Mach M; Wahren B; Borrebaeck CA
J Virol; 1993 Feb; 67(2):703-10. PubMed ID: 7678304
[TBL] [Abstract][Full Text] [Related]
16. Different antibody response to a neutralizing epitope of human cytomegalovirus glycoprotein B among seropositive individuals.
Ayata M; Sugano T; Murayama T; Sakamuro D; Takegami T; Matsumoto Y; Furukawa T
J Med Virol; 1994 Aug; 43(4):386-92. PubMed ID: 7525866
[TBL] [Abstract][Full Text] [Related]
17. Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step.
Ye X; Su H; Wrapp D; Freed DC; Li F; Yuan Z; Tang A; Li L; Ku Z; Xiong W; Jaijyan D; Zhu H; Wang D; McLellan JS; Zhang N; Fu TM; An Z
PLoS Pathog; 2020 Aug; 16(8):e1008736. PubMed ID: 32745149
[TBL] [Abstract][Full Text] [Related]
18. B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies.
Pötzsch S; Spindler N; Wiegers AK; Fisch T; Rücker P; Sticht H; Grieb N; Baroti T; Weisel F; Stamminger T; Martin-Parras L; Mach M; Winkler TH
PLoS Pathog; 2011 Aug; 7(8):e1002172. PubMed ID: 21852946
[TBL] [Abstract][Full Text] [Related]
19. A Novel Strain-Specific Neutralizing Epitope on Glycoprotein H of Human Cytomegalovirus.
Thomas M; Kropff B; Schneider A; Winkler TH; Görzer I; Sticht H; Britt WJ; Mach M; Reuter N
J Virol; 2021 Aug; 95(18):e0065721. PubMed ID: 34160252
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.
Lilleri D; Kabanova A; Lanzavecchia A; Gerna G
J Clin Immunol; 2012 Dec; 32(6):1324-31. PubMed ID: 22836657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
